Supplementary Table 1 from Phase I Study Utilizing a Novel Antigen-Presenting Cell–Targeted Vaccine with Toll-like Receptor Stimulation to Induce Immunity to Self-antigens in Cancer Patients

Authors:
  • MMMichael A. Morse
    Michael A. Morse
  • RCRobert Chapman
    Robert Chapman
  • JPJohn Powderly
    John Powderly
  • KBKimberly Blackwell
    Kimberly Blackwell
  • TKTibor Keler
    Tibor Keler
  • JGJennifer Green
    Jennifer Green
  • RRRenee Riggs
    Renee Riggs
  • LHLi-Zhen He
    Li-Zhen He
  • VRVenky Ramakrishna
    Venky Ramakrishna
  • LVLaura Vitale
    Laura Vitale
  • BZBiwei Zhao
    Biwei Zhao
  • SBStephen A. Butler
    Stephen A. Butler

Abstract
Supplementary Table 1 from Phase I Study Utilizing a Novel Antigen-Presenting Cell–Targeted Vaccine with Toll-like Receptor Stimulation to Induce Immunity to Self-antigens in Cancer Patients